Medical news of Remedium.ru portal is the most update information on pharmaceutical and medical equipment market

Journals

REMEDIUM

The periodical about the pharmaceutical and medical equipment markets

ROSSIYSKIE APTEKI

(Russian pharmacies) - specialized periodical edition for pgarmacy professionals

MEDITSINSKY SOVET

Medical Council - Scientific Journal for Physicians


Home

News

Russia has long been considered a prime market for Western biopharma companies in search of new sources of growth. And companies ranging from Pfizer to AstraZeneca have been clamoring to comply with President Vladimir Putin’s demand that they ally with local producers and establish manufacturing plants in Russia. But now Russia is pushing back on an issue that has raised concerns around the world: cancer drug prices.
US pharma giant Pfizer (NYSE: PFE) is considering building another manufacturing plant in Russia during the next several years, which is expected to be located in the Tatarstan Republic, one of Russia’s richest and economically developed regions.
Russian state corporation Rostec has announced an agreement with an Arabian pharmaceutical producer for the establishment of a joint venture – Pharma Aid Ltd - that will focus on the manufacture drugs for the treatment of HIV and hepatitis.
Russian biotech Biocad expects to double the amount of people in Bolivia and Honduras able to receive rituximab with its biosimilar version of the cancer drug, which the company expects to launch in the third quarter of this year.
JSE Limited listed Aspen Pharmacare (APN), a leading pharmaceutical company in the southern hemisphere, has announced that a memorandum of understanding (“MOU”) has been concluded between Aspen’s Russian business and the Vladivostok Far Eastern Federal University (“FEFU”).
News 1 - 5 из 898
Начало | Пред. | 1 2 3 4 5 | След. | КонецВсе

Remedium group

REMEDIUM

publishing house

CLIFAR

programmer of electronic software products

R-PRESS

advertisement agency

REPRENT

rent-a-rep company